CION Ameerpet
Pancreatic Cancer · Types, Location & Resectability · Reviewed by CION Oncologists
Pancreatic cancer staging — TNM stage versus resectability
Two systems are used to describe pancreatic cancer, and they answer two different questions. The TNM stage group says how far the disease has travelled. The resectability category says whether an operation could remove all of it. This page explains both, and why your team will talk about the second one far more.
- Stage and resectability are separate — one describes spread, the other describes whether surgery is possible.
- The stage number is not the plan — the category, the tumour type and your general health decide treatment.
- A stage can be revised — a clinical stage from scans is confirmed or corrected on tissue later.
- A stage describes a group — it is a shared label for comparison, never a forecast for one person.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres Across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start here
Two Systems Are in Use, and They Answer Different Questions
If you have just been handed a scan report or a biopsy report, you are probably looking for one thing on it: a number. Most people expect that number to tell them how serious this is and what happens next. It does neither, and understanding why will save you a great deal of confusion over the coming weeks.
Pancreatic cancer staging is done with the TNM system, the same framework used across almost every solid cancer. Three separate observations are recorded — the tumour itself (T), the lymph nodes (N) and whether disease has appeared beyond the pancreas (M) — and those three are then combined into a single stage group, usually written as stage 1 through stage 4. It is a description of how far the disease has travelled, built so that hospitals and registries anywhere in the world describe the same situation in the same words.
Alongside it sits a second system your surgical and oncology team will actually spend most of their time on: the resectability category. Following NCCN guidance, a pancreatic tumour is placed into one of four groups — resectable, borderline resectable, locally advanced, or metastatic — based on exactly how much contact the tumour makes with the major arteries and veins that run immediately behind the pancreas. That contact is judged on a dedicated pancreatic-protocol contrast CT, and it is the finding that decides whether an operation could remove everything.
This is why the conversation in clinic can feel oddly disconnected from the report in your hand. Two people can share the same stage group and be offered entirely different plans, because one tumour sits clear of the arteries and the other wraps around them. If you want the surgical half of this in detail, what resectable pancreatic cancer means sets out the criteria properly, and the complete pancreatic cancer guide covers the wider picture.
Did you know? In the current AJCC staging manual, the node category for pancreatic cancer is graded by how many lymph nodes contain cancer rather than by where those nodes sit — a deliberate change, made because node count proved the more reliable descriptor across large surgical series. NCCN, meanwhile, keeps resectability as an entirely separate, imaging-based judgement about arterial and venous contact. Two different bodies of expert work, two different questions, and no arithmetic that converts one into the other. That is the single most useful thing to understand about a pancreatic report: the stage group tells your team how far the disease has gone, and the resectability category tells them what can be done about it.
Reading your report
What Each Part of a TNM Report Actually Describes
Reports are written for other clinicians, not for you. Here is what the shorthand on yours is recording.
T — the tumour
Its size, and what it is touching
The lower T categories are separated by size thresholds measured on the scan. The highest category is reserved for tumours involving the major arteries behind the pancreas, whatever their size.
N — the lymph nodes
How many nodes contain cancer cells
Not simply whether nodes are involved, but how many. A small number of involved nodes and a larger number sit in different categories, and this is only fully known if an operation takes place.
M — spread
Whether disease has appeared elsewhere
Most often the liver or the lining of the abdomen, sometimes the lungs. Any confirmed distant deposit makes the stage group 4 — see what stage 4 pancreatic cancer means.
The stage group
The three letters combined into one number
T, N and M are read together against a published table to give one of the pancreatic cancer stages, from stage 1 to stage 4. The table does the combining; nobody estimates it.
c, p and y prefixes
When and how the stage was worked out
A small c means the stage was judged clinically, from scans. A p means it was confirmed by a pathologist on removed tissue. A y in front means treatment was given before that assessment.
Type and grade
Recorded separately from the stage
Grade describes how abnormal the cells look, and tumour type matters even more — pancreatic ductal adenocarcinoma and a neuroendocrine tumour behave very differently at the same stage.
Side by side
Stage Group and Resectability Category, Compared
Both appear in your notes. Only one of them is used to decide whether an operation is on the table.
| The question | TNM stage group | Resectability category |
|---|---|---|
| What is it built from? | Tumour size and arterial involvement, the number of involved lymph nodes, and any distant deposits. | The degree of contact between the tumour and named arteries and veins on a pancreatic-protocol CT. |
| What does it actually answer? | How far this cancer has travelled, described in a way any hospital anywhere can read. | Whether an operation could remove all of it, with clear margins, as things stand today. |
| Who leans on it most? | Pathologists, cancer registries and the authors of published studies. | Your surgeon, your medical oncologist and the tumour board that reviews your case. |
| When is it decided? | Clinically at diagnosis, then confirmed or revised by the pathologist if surgery goes ahead. | At diagnosis, and reassessed on every restaging scan after treatment given first. |
| Can it change? | The clinical stage can be revised when better evidence arrives, most often after an operation. | Yes. Chemotherapy given first can pull a borderline tumour back from the vessels and make surgery possible. |
| What does it not tell you? | Whether an operation is possible for you, and nothing at all about how you will respond. | Nothing about tumour type or grade, both of which change the systemic plan. |
If your report has a stage on it but nobody has told you which resectability group you are in, that is the question to ask next — it is the one that shapes the plan. Pancreatic cancer treatment in Hyderabad sets out what follows from each category. Book a free consultation or call 1800 202 8726.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
The Category Matters More Than the Number
One conversation separates what the stage describes from what actually decides your treatment.
What actually happens
How Your Stage and Category Are Established
-
A pancreatic-protocol contrast CT
Not an ordinary abdominal scan. The timing of the contrast is set specifically to show the arteries and veins behind the pancreas, because that is where the resectability answer lives.
Ordered and reported in-house at CION -
Tissue, so the type is certain
A sample is usually taken by endoscopic ultrasound with a fine needle. Type matters more than the stage number, because a neuroendocrine tumour is staged and treated on a different track entirely.
Biopsy coordinated with specialist endoscopy partners -
Baseline bloods and CA 19-9
Taken at the outset so the trend can be followed later. A single reading says little on its own; the direction it moves over successive tests says considerably more.
In-house at CION -
Extra imaging only where it changes something
MRI or MRCP where the liver or the ducts need clarifying. A PET scan, or a look inside with a camera before a planned operation, only where the answer would genuinely alter the plan.
MRI/MRCP in-house; PET-CT and staging laparoscopy coordinated with partner centres -
The tumour board assigns both
Scans, pathology and your general health are reviewed together by medical oncology, radiation oncology and the surgical partners, rather than by one doctor working alone.
Tumour board at CION -
Restaging, written into the plan in advance
Where treatment is given before any operation, the reassessment point is agreed at the start — so everyone knows when the resectability question gets asked again, and on which scan.
Systemic therapy and radiation in-house at CION
Plainly stated
What CION Delivers, and What Is Coordinated
Your first consultation is free and lasts 45 minutes. It is a proper review of the reports you already have, not a booking appointment — and if all you want from it is your stage and your resectability category explained in plain language, that is a perfectly good reason to come.
Delivered in-house at CION, across 35+ centres in Telangana and Andhra Pradesh: the ordering and reporting of pancreatic-protocol contrast CT, MRI/MRCP, CA 19-9 and routine bloods; the multidisciplinary tumour-board review that assigns the resectability category; medical oncology — chemotherapy before surgery, after surgery and for advanced disease, PARP-inhibitor-class maintenance where an inherited BRCA change is found, immune checkpoint inhibitor therapy where the tumour is mismatch-repair deficient, and systemic treatment for neuroendocrine tumours including somatostatin-analogue-class therapy; radiation, chemoradiation and SBRT; genetic counselling; nutrition and pancreatic enzyme replacement; pain relief, psycho-oncology and supportive care; and survivorship follow-up.
Coordinated with specialist HPB, gastroenterology and endoscopy partner centres, and may be billed there: the endoscopic ultrasound and biopsy that confirms the diagnosis; ERCP and biliary or duodenal stenting; staging laparoscopy; all pancreatic surgery, including the Whipple procedure and distal pancreatectomy; coeliac plexus block for pain; PET-CT and DOTATATE PET; and peptide receptor radionuclide therapy. We arrange these, we sit in on the decisions, and we tell you in advance where each one happens and who will invoice you. We do not describe them as our own theatre or endoscopy lists, because they are not.
Take this list with you
Six Questions Worth Asking About Your Own Stage
- Which resectability group am I in today? Ask for the word — resectable, borderline, locally advanced or metastatic — and which scan it was judged on.
- Is my stage clinical or pathological? A stage from scans alone is a careful estimate. A stage confirmed on removed tissue is a measurement.
- What type of tumour is it exactly? Whether this is pancreatic ductal adenocarcinoma or a neuroendocrine tumour changes the whole plan, not just a line on the form.
- Was my CT a pancreatic-protocol study? If it was a general abdominal scan, the vessel question may not have been answerable on it, and repeating it may be worth the extra week.
- If I am borderline, what would move me into the operable group? Ask what treatment is planned first and when the resectability question will be asked again — what resectable pancreatic cancer means explains what the team is aiming for.
- Which parts of my care are billed where? If your scans and chemotherapy sit with one team and your surgery or endoscopy with a partner centre, ask for that split in writing early.
Bring the scan report and the pathology report to your first appointment. Those two documents answer more about your stage than anything you will find online. Book a free consultation or call 1800 202 8726.
Take the next step
Understanding the Report Makes the Next Decision Easier
Knowing what your stage does and does not say takes the guesswork out of the weeks ahead. We walk this journey with you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Pancreatic cancer staging - your questions answered
What is the difference between the stage of my pancreatic cancer and whether it can be operated on?
They are two separate judgements. The stage group is a TNM description of how far the cancer has travelled: the tumour, the lymph nodes and whether disease has appeared elsewhere, combined into a single number using a published table. Resectability is a different assessment made on a pancreatic-protocol contrast CT, and it asks only one question - how much contact does the tumour make with the major arteries and veins behind the pancreas, and could an operation therefore remove all of it. The stage number is what registries and published studies use. The resectability category is what your surgeon and your oncologist use to decide the plan. Two people with the same stage group can be offered completely different treatment, which is why the category is the more useful thing to ask about.
What do the letters T, N and M actually stand for on my report?
T describes the tumour itself. The lower categories are separated by size thresholds measured on the scan, while the highest category is reserved for tumours involving the major arteries behind the pancreas regardless of how large they are. N describes the lymph nodes, and importantly it records how many contain cancer rather than simply whether any do, which is why it is only fully known if an operation takes place. M records whether disease has been confirmed away from the pancreas, most often in the liver or the lining of the abdomen. Those three are read together against a published table to give one of the pancreatic cancer stages. Grade and tumour type are recorded separately, and both matter as much as the stage number does.
Why does my report say cT3 or ypT2 instead of just a stage number?
The small letters record how and when the stage was worked out, which changes how much weight it carries. A c means clinical: the stage was judged from imaging and examination, before any tissue was removed. A p means pathological: a pathologist measured the tumour and counted the lymph nodes in the specimen after an operation, so it is a measurement rather than an estimate. A y placed in front of either means treatment was given before that assessment was made, so the finding describes the situation after chemotherapy or radiation rather than at first diagnosis. This matters because a clinical stage can be revised once tissue is examined, and because a stage recorded after treatment is not directly comparable with one recorded before it.
Can my pancreatic cancer stage or resectability category change over time?
Both can, and for different reasons. The clinical stage can be revised when better evidence arrives, which most commonly happens after an operation, when the pathologist has the whole specimen and can count nodes properly rather than estimate from a scan. The resectability category can change with treatment, and this is one of the genuinely hopeful ideas in pancreatic cancer care. A borderline tumour touching the vessels can sometimes be pulled back by chemotherapy given first, occasionally with radiation added, so that an operation which was not safely possible at diagnosis becomes possible later. That is why treatment plans usually include an agreed restaging point, written down at the start, rather than being reviewed only when somebody remembers to ask.
Does a higher stage number mean there is less that can be done?
It changes what is realistic, but it does not close the conversation. A higher stage generally means an operation is less likely to be the first step, and that systemic treatment moves to the front of the plan. It does not mean nothing is offered. Chemotherapy, and in some situations radiation or chemoradiation, is given with clear goals: controlling the disease, relieving symptoms such as pain or jaundice, protecting weight and digestion, and keeping you well enough to carry on with ordinary life. A stage also describes a group of people who were staged the same way, not you specifically. Your tumour type, your general health and how you respond to the first line of treatment all shape what happens next.
Is stage 4 pancreatic cancer the same as being told there is no treatment?
No. Stage 4 means disease has been confirmed away from the pancreas, most often in the liver, and that surgery to remove the primary tumour is not the route. It is a serious situation, and it would be dishonest to describe it otherwise. But treatment at this stage is active rather than nominal, and it is aimed at controlling the disease and protecting how you feel day to day. Systemic therapy, symptom control, nutrition and enzyme support, and pain management all have a real role, and neuroendocrine tumours found at this stage behave quite differently from adenocarcinoma. Our page on what stage 4 pancreatic cancer means goes through this properly rather than in a single paragraph.
What does CION do about staging, and what happens at the first visit?
The first consultation is free and lasts 45 minutes, and it is a genuine review of the reports you already hold. Bring your scan report, your biopsy report if you have one, and any recent bloods. We order and report pancreatic-protocol CT, MRI and MRCP, CA 19-9 and routine bloods in-house across 35+ centres, and our tumour board assigns the resectability category with medical oncology, radiation oncology and the surgical partners in the room together. Chemotherapy, radiation, chemoradiation and SBRT, genetic counselling, nutrition and enzyme support and supportive care are delivered by us. The endoscopic ultrasound and biopsy, staging laparoscopy, PET-CT and any pancreatic surgery are coordinated with specialist partner centres and may be billed there. We will tell you which is which before anything is booked.
Medical disclaimer: This page explains how pancreatic cancer is staged with the TNM system and how that differs from the NCCN resectability categories, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information; your own stage, resectability category and treatment plan depend on your individual imaging, pathology and general health, and should be discussed with your treating team. Pancreatic-protocol CT, MRI/MRCP, CA 19-9 and blood test ordering and reporting, tumour-board review, chemotherapy, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme support, pain relief, psycho-oncology and survivorship care are delivered by CION; endoscopic ultrasound and biopsy, ERCP and stenting, staging laparoscopy, all pancreatic surgery, coeliac plexus block, PET-CT and DOTATATE PET, and peptide receptor radionuclide therapy are coordinated with specialist HPB, gastroenterology and endoscopy partner centres and may be billed there.